← FDA Drug Approvals (Drugs@FDA)

NAPROSYN

NDA · New Drug Application · Sponsor: ATNAHS PHARMA US · Approved 1987-03-23

Drug application

FDA Application #
NDA018965
Application type
New Drug Application
Brand name
NAPROSYN
Generic name
NAPROXEN
Active ingredients
NAPROXEN
Dosage form
SUSPENSION
Route
ORAL
Marketing status
Prescription
Sponsor
ATNAHS PHARMA US
Manufacturer
Acella Pharmaceuticals, LLC
First approval
1987-03-23

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown